Maha FDA seeks state L&J dept's view regarding HC order lifting Maggi ban

State govt will decide whether or not to file the petition in the Supreme Court against the Bombay HC judgement

Sanjay Jog Mumbai
Last Updated : Aug 23 2015 | 11:51 PM IST
Maharashtra’s food and drug administration (FDA) has sought the opinion of the department of law and judiciary on approaching the Supreme Court against the high court order lifting the ban imposed on Nestlé India’s Maggi noodles.

“FDA has sought the law department’s opinion on the court’s observation on the violation of principles of natural justice and the Indian laboratories where Maggi were tested were not accredited and, therefore, not competent to give findings on lead content. Besides, the department’s view has also been sought on the issue of high court ordering rechecking of samples, which are with Nestlé and not allowing the sealed random samples drawn as per the procedure by the state FDA,’’ commissioner Harshdeep Kamble told Business Standard.

Read more from our special coverage on "NESTLE MAGGI CONTROVERSY"


He informed the state food regulator expects to receive the department’s opinion within a week, which will then be referred to state FDA minister Girish Bapat for approval.

Based on the department’s opinion, the government will decide whether or not to file the petition in the Supreme Court against the high court judgment.

The court in its order delivered on August 13 had upheld Nestle India's argument that the "principles of natural justice." The company on its part had claimed that the ban was "unauthorised, arbitrary, unconstitutional for violating right to equality and trade'' and had violated the principles of natural justice as it had not been given proper hearing.

This apart,  the high court also observed that procedures were not followed by the Food Safety Standard Association of India (FSSAI)  and the state FDA before the imposition of ban. Further, the court had also questioned the manner in which a show cause notice was not issued before the ban.

Moreover, the high court raised serious doubts on the results of  the samples tested at authorized laboratories that were accredited to the National Accreditation Board for Testing and Calibration Laboratories.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 23 2015 | 11:51 PM IST

Next Story